Work with the University of Exeter
Innovate
Microbiology collaborations
We can help you innovate, grow your business, gain a new competitive edge or break into new markets. Whether you want to develop new products and services, find new ways of operating, reduce costs, improve efficiency or access the latest technologies, our world class research can help you find a solution.
Our professional staff will help ensure you get the best possible results for your project and provide a single point of contact to manage your relationship with the University throughout your work.
The Universities of Exeter and Cape Town (UCT) have joined forces to create the world’s first international research centre for tackling fungal infections; the AFGrica Unit, which opened in Cape Town in August 2017.
Find out more >>
The Environmental Dimension of Antimicrobial Resistance group at ECEHH have been working with AstraZeneca for several years focusing on the role of environmental pharmaceutical residues in the evolution of AMR. AZ has co-funded four PhD studentships in the EDAR (Environmental Dimensions of Antibiotic Resistance) group.
Attomarker is a pioneering spin-out company based at the University of Exeter. Founded by Andrew Shaw, Associate Professor of Physical Chemistry, the company has developed one of the first antibody tests for COVID-19.
Find out more >>
We have worked with DSTL to characterise the genetic makeup of a range of bacterial pathogens of humans and to identify genes which are essential for bacterial growth. These studies will now allow new ways to identify disease-causing strains of bacteria and will allow DSTL to develop new types of drugs which block the ability of bacteria to cause disease.
Stefano Pagliara has been working with DSTL on establishing novel therapeutics to fight antimicrobial resistant pathogens. DSTL has co-funded two PhD studentships in this area.
Through continued collaborative working, the GW4 Network aims to tackle the global challenge of AMR. We are working with the University of Bristol on the Medical Research Foundation’s National PhD Training Programme in Antimicrobial Resistance Research, which will train new researchers to explore ways to tackle antimicrobial resistance. Exeter is represented on the GW4 AMR Alliance Steering Committee by Prof Adilia Warris, Prof Steve Hinchliffe and Prof Will Gaze.
Find out more >>
Established in 2012 by Dr Christopher Thornton, ISCA Diagnostics is a University of Exeter spin-out company specialising in point-of-care tests for life-threatening fungal infections of humans.
Find out more >>
Our research is intrinsically linked with the NHS, regionally we help build clinical research excellence capacity as a partner on PenCLAHRC, guiding NHS clinical practice and research in Devon and Cornwall. We are supporting the Royal Devon and Exeter hospital (RD&E) in the battle against Covid-19 through loaning equipment and improving test capacity.